Chadwick’s appointment — which goes into effect on April 22, 2024 — follows an extensive search process conducted by Insulet. That search spanned nearly six months after former CFO Wayde McMillan left for 3M’s Solventum healthcare spinoff in October.
Lauren Budden served as interim CFO and treasurer following McMillan’s departure. The company plans for her to continue in her role as group VP, chief accounting officer and controller.
Chadwick now joins Acton, Massachusetts-based Insulet, a developer of automated insulin delivery technology, with more than 30 years of experience in propelling growth within organizations.
“We are thrilled to welcome Ana to Insulet,” said Jim Hollingshead, Insulet president and CEO. “She is an experienced public company CFO, and her achievements throughout her career demonstrate that she is a proven, highly accomplished, and versatile executive. Ana is known for her insight, intellectual agility, and compelling and collaborative leadership. She will be a strong addition to our leadership team as we continue to scale and expand our business.”
Get the full story at our sister site, Drug Delivery Business News.